同期Cox迷宫术在无二尖瓣病变患者中的长期安全性与有效性
该研究前瞻性随访711例接受同期Cox迷宫术的患者,其中238例未行二尖瓣手术,经倾向评分匹配后每组164例。匹配后两组早期结局相似,5年无卒中生存率(96.1% vs 96.6%)及停用抗心律失常药物后窦性心律比例(68% vs 63%)均无显著差异。结论认为同期Cox迷宫术在二尖瓣与非二尖瓣手术中安全有效,手术决策应基于房颤病理生理和患者获益而非同期手术类型。
要点
- 无二尖瓣病变患者同期Cox迷宫术的长期安全性和有效性与二尖瓣手术组相当。
- 匹配后5年无卒中生存率二尖瓣组96.1%、非二尖瓣组96.6%,差异无统计学意义。
- 术后5年停用抗心律失常药物后窦性心律比例分别为68%和63%,组间无显著差异。
核心结论
- 同期Cox迷宫术在二尖瓣与非二尖瓣手术中安全有效,结局相当。
- 手术决策应基于房颤病理生理和患者获益,而非同期手术类型。
研究设计与样本
- 前瞻性随访自2005年9月起接受同期Cox迷宫术的患者共711例。
- 其中238例未行二尖瓣手术,经倾向评分匹配后二尖瓣组与非二尖瓣组各164例。
主要发现
- 匹配前二尖瓣组更年轻(65 vs 67岁,P=.047),euroSCORE II更高(3.2% vs 2.6%,P=.002),左房更大(5.3 vs 4.8 cm,P<.001)。
- 匹配后两组早期结局相似。
- 匹配后5年累积无卒中生存率二尖瓣组96.1%、非二尖瓣组96.6%(P=.667)。
- 匹配后各时间点停用抗心律失常药物后窦性心律比例相似,5年时为68% vs 63%(P=.492)。
临床怎么用
- 对于无二尖瓣病变的房颤患者,可考虑同期行Cox迷宫术,其安全性和有效性与二尖瓣手术组相当。
- 不应因患者无需左房切开而回避同期Cox迷宫术,决策应基于房颤病理生理和患者获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Newly published guidelines made the highest level recommendation for surgical treatment for atrial fibrillation. However, the number of patients without a mitral valve procedure with atrial fibrillation who are treated with concomitant surgical ablation is still low (15%-25%), because surgeons are reluctant to perform procedures in patients who would not otherwise require left atriotomy. The purpose of this study was to compare the outcomes of concomitant Cox maze with and without mitral valve procedures. METHODS: Patients who underwent concomitant Cox maze procedures were prospectively followed since September 2005. Of the 711 patients, 238 did not receive mitral valve surgery. Propensity score matching was conducted to balance preoperative characteristics between patients with and without mitral valve procedures (164/group after matching). RESULTS: Before matching, patients in the mitral valve group were younger (65 vs 67 years, P = .047) and had higher euroSCORE II (European System for Cardiac Operative Risk Evaluation; 3.2% vs 2.6%, P = .002), larger mean left atrial size (5.3 vs 4.8 cm, P < .001), and shorter median atrial fibrillation duration (19 vs 25 months, P = .064). Early outcomes were similar for the matched groups. Cumulative 5-year freedom from stroke did not differ between matched mitral valve and non-mitral valve groups (96.1% vs 96.6%, P = .667). At each time point, the proportion in sinus rhythm off antiarrhythmic medications was similar for the matched groups, including 5 years after surgery (68% vs 63%, P = .492). CONCLUSIONS: The Cox maze procedure is safe and effective with comparable outcomes when performed concomitant to mitral valve or non-mitral valve surgery. Surgeons should base the decision to perform surgical ablation procedures on atrial fibrillation pathophysiology and the benefit to patients, not on the type of concomitant procedure.
引用
- Ad N, Holmes SD, Rongione AJ, et al. The long-term safety and efficacy of concomitant Cox maze procedures for atrial fibrillation in patients without mitral valve disease. J Thorac Cardiovasc Surg. 2018. PMID: 30578060. doi:10.1016/j.jtcvs.2018.09.131
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。